Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 131   

Articles published

4502 6,326.00 -9.00 (-0.14%)
price chart
Recursion Pharmaceuticals Announces Research Collaboration with Takeda to ...
... company that combines innovative biological science with artificial intelligence to discover new disease treatments at scale, today announced the formation of a research collaboration agreement with Takeda Pharmaceutical Company Limited ( TSE : 4502).
Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery ...
OSAKA, Japan & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a partnership to discover and develop ...
Market Desk: Reviewing the Numbers for Takeda Pharmaceutical Company Limited ...
Investors are constantly examining different company financial indicators to assess trading opportunities. Takeda Pharmaceutical Company Limited (TSE:4502) presently has an EV or Enterprise Value of 6127308230. The EV is used to show how the market ...
Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based ...
OSAKA, Japan & SAN DIEGO & STOCKHOLM--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), Karolinska Institutet (“KI”) and The Structural Genomics Consortium (“SGC”) today announced a combined pre-competitive ...
Takeda Offers Restructuring And Portfolio Upside
Takeda has shown it's serious about restructuring and prioritizing profits over size, as it has repositioned itself toward markets that will support better pricing and margins long term.
Takeda Pharmaceutical Company Limited (TSE:4502): A Look at the Company's ...
The ROIC Quality of Takeda Pharmaceutical Company Limited (TSE:4502) is 2.829975. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC.
Piotroski F-Score Under Review For Takeda Pharmaceutical Company Limited (TSE ...
The Piotroski F-Score of Takeda Pharmaceutical Company Limited (TSE:4502) is 5. The Piotroski F-Score is a scoring system between 1-9 that determines a firm's financial strength.
Takeda Welcomes The Honorable Susana Mendoza As Guest Speaker At Deerfield ...
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Takeda Named To 2017 Working Mother "100 Best Companies" For Leadership In ...
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Arcturus expands partnership with J&J into hepatitis B
The biotech has also previously hooked up with Takeda Pharmaceutical Company Ltd. to develop RNA-based drugs for nonalcoholic steatohepatitis (NASH) and signed a research collaboration with Ultragenyx Pharmaceutical Inc. for work in rare diseases.